GLUE vs. ^XMI
Compare and contrast key facts about Monte Rosa Therapeutics, Inc. (GLUE) and NYSE Arca Major Market Index (^XMI).
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: GLUE or ^XMI.
Key characteristics
GLUE | ^XMI | |
---|---|---|
YTD Return | 4.78% | 13.64% |
1Y Return | -1.66% | 20.98% |
3Y Return (Ann) | -42.37% | 8.37% |
Sharpe Ratio | -0.01 | 2.07 |
Daily Std Dev | 110.94% | 10.07% |
Max Drawdown | -94.08% | -47.65% |
Current Drawdown | -85.97% | 0.00% |
Correlation
The correlation between GLUE and ^XMI is 0.27, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
Performance
GLUE vs. ^XMI - Performance Comparison
In the year-to-date period, GLUE achieves a 4.78% return, which is significantly lower than ^XMI's 13.64% return. The chart below displays the growth of a $10,000 investment in both assets, with all prices adjusted for splits and dividends.
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
GLUE vs. ^XMI - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for Monte Rosa Therapeutics, Inc. (GLUE) and NYSE Arca Major Market Index (^XMI). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Drawdowns
GLUE vs. ^XMI - Drawdown Comparison
The maximum GLUE drawdown since its inception was -94.08%, which is greater than ^XMI's maximum drawdown of -47.65%. Use the drawdown chart below to compare losses from any high point for GLUE and ^XMI. For additional features, visit the drawdowns tool.
Volatility
GLUE vs. ^XMI - Volatility Comparison
Monte Rosa Therapeutics, Inc. (GLUE) has a higher volatility of 36.65% compared to NYSE Arca Major Market Index (^XMI) at 3.24%. This indicates that GLUE's price experiences larger fluctuations and is considered to be riskier than ^XMI based on this measure. The chart below showcases a comparison of their rolling one-month volatility.